PACS PACS Group, Inc.
PACS PACS Group, Inc.
Healthcare · Medical Care Facilities
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $35.61 · VWAP $34.58 · +35.7% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $13M sold last open-market sell Hancock Mark
Cluster CEO, COO + 1 other sold $17.9M, Sep 9–17
Coverage
1 watchlist
PACS Price Structure
Loading timeframes…
Peers
Every watchlist PACS belongs to, members best 30-day change first — PACS highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How PACS's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about PACS from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 8 days ago · Oct 9
- PACS Group president & COO Joshua Jergensen sells $1.73m in stock By Investing.com
- PACS group co-founder, CEO Jason Hulse sells $886,569 in stock By Investing.com
- PACS Group (PACS) Q2 2026 Earnings Results & Call Transcript
- PACS Group, Inc. Reports Second Quarter 2026 Results :: PACS Group, Inc. (PACS)
- PACS Group (PACS) Is Up 22.1% After Q1 Beat, Guidance Hike and Buyback Launch
PACS research tape
50 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.